Worldwide deal for the marketing and distribution of Asuragen's cystic fibrosis screening products
Digene gets exclusive rights to market the products, as well as follow-on products; Asuragen gets an up-front payment and potential milestone payments (4/19)#
Prisma Biotech Corp.* (Taiwan)
Prisma will promote and sell CombiMatrix products in Taiwan, China and certain other countries
Prisma also can synthesize content onto CombiMatrix CustomArrays and sell those arrays to end customers; terms were not disclosed (4/28)
Inhibitex terminated deal covering the manufacture of its Veronate product
The move follows a failed Phase III trial of Veronate for preventing hospital-associated infections in premature, very low-birth infants (4/28)
* Private companies are indicated with an asterisk.
# Item occurred before the time frame of this chart but was not included in the previous chart.
Unless otherwise noted, stock symbols listed are on the Nasdaq market.